scholarly article | Q13442814 |
P2093 | author name string | Chih-Yi Chen | |
De-Wei Wu | |||
Huei Lee | |||
Lee Wang | |||
Ya-Wen Cheng | |||
Ming-Ching Lee | |||
Po-Ming Chen | |||
Lung-Hung Tsai | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung cancer | Q47912 |
tumor invasion | Q60750433 | ||
P304 | page(s) | 1796-1806 | |
P577 | publication date | 2012-09-11 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer | |
P478 | volume | 181 |
Q40099137 | A combination of anti-PD-L1 mAb plus Lm-LLO-E6 vaccine efficiently suppresses tumor growth and metastasis in HPV-infected cancers. |
Q36799733 | A distinct role for interleukin-6 as a major mediator of cellular adjustment to an altered culture condition |
Q49306989 | Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer |
Q37190195 | Environmental exposure and HPV infection may act synergistically to induce lung tumorigenesis in nonsmokers. |
Q48259597 | FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction |
Q39139077 | Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition |
Q38881068 | Human papillomavirus and lung cancinogenesis: an overview |
Q33798441 | Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis |
Q53082211 | IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation. |
Q38982850 | IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation |
Q87256734 | In utero exposure to second-hand smoke activates pro-asthmatic and oncogenic miRNAs in adult asthmatic mice |
Q37200413 | Interleukin-6 cytokine: a multifunctional glycoprotein for cancer |
Q90781798 | Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis |
Q44577216 | MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer |
Q36595028 | MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression |
Q38881938 | Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability |
Q39085744 | Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression |
Q36299328 | Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer |
Q35532904 | Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis |
Q37362672 | Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. |
Q36141453 | Retracted: MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1 |
Q58604428 | Synergistic Action of 1,2-Epoxy-3 (3- (3,4-dimethoxyphenyl)- 4H-1-benzopiyran-4-on) Propane with Doxorubicin and Cisplatin through Increasing of p53, TIMP-3, and MicroRNA-34a in Cervical Cancer Cell Line (HeLa) |
Q92277219 | TIMP-3 as a therapeutic target for cancer |
Q34110436 | TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. |
Q53687206 | TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production. |
Q38785433 | TIMPs: versatile extracellular regulators in cancer |
Q38987143 | c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT. |
Search more.